Skip to main content

Navigation group

Type at least 3 characters
1,130 articles

Articles

Clinical Trial

Published on 07 Feb 2024

Tolerability and efficacy of the cancer vaccine UV1 in patients with recurrent or metastatic PD-L1 positive head and neck squamous cell carcinoma planned for first-line treatment with pembrolizumab – the randomized phase 2 FOCUS trial

in Head and Neck Cancer

  • Anna Brandt
  • Christoph Schultheiss
  • Konrad Klinghammer
  • Philippe Schafhausen
  • Chia-Jung Busch
  • Markus Blaurock
  • Axel Hinke
  • Mareike Tometten
  • Andreas Dietz
  • Urs MĂĽller-Richter
Tolerability and efficacy of the cancer vaccine UV1 in patients with recurrent or metastatic PD-L1 positive head and neck squamous cell carcinoma planned for first-line treatment with pembrolizumab – the randomized phase 2 FOCUS trial
Frontiers in Oncology
doi 10.3389/fonc.2024.1283266
  • 2,429 views
  • 1 citation

Original Research

Published on 29 Jan 2024

Determinants of circulating calcitonin value: analysis of thyroid features, demographic data, anthropometric characteristics, comorbidities, medications, and smoking habits in a population with histological full exclusion of medullary thyroid carcinoma

in Head and Neck Cancer

  • Pierpaolo Trimboli
  • Giuseppe Peloni
  • Dorotea Confalonieri
  • Elena Gamarra
  • Tommaso Piticchio
  • Francesco Frasca
  • Petra Makovac
  • Arnoldo Piccardo
  • Lorenzo Ruinelli
Determinants of circulating calcitonin value: analysis of thyroid features, demographic data, anthropometric characteristics, comorbidities, medications, and smoking habits in a population with histological full exclusion of medullary thyroid carcinoma
Frontiers in Oncology
doi 10.3389/fonc.2024.1278816
  • 805 views
  • 1 citation